US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.980
  • -0.400-6.27%
Close May 17 16:00 ET
  • 6.000
  • +0.020+0.33%
Post 17:54 ET
502.11MMarket Cap-2083P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
305.63%5.7M
505.77%11.76M
408.30%5.14M
235.52%3.12M
2.09M
1.4M
1.94M
1.01M
929K
0
Operating revenue
305.63%5.7M
505.77%11.76M
408.30%5.14M
235.52%3.12M
--2.09M
--1.4M
--1.94M
--1.01M
--929K
--0
Cost of revenue
Gross profit
Operating expense
4.82%62.54M
40.12%234.88M
21.28%59.09M
23.80%55.45M
43.81%60.68M
86.88%59.66M
92.53%167.63M
49.73%48.72M
90.58%44.79M
148.71%42.19M
Selling and administrative expenses
12.83%14.16M
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
59.68%9.59M
156.06%9.07M
-General and administrative expense
12.83%14.16M
33.05%49.94M
7.37%12.28M
21.83%11.69M
47.97%13.42M
68.84%12.55M
98.96%37.53M
73.28%11.44M
59.68%9.59M
156.06%9.07M
Research and development costs
2.69%48.38M
42.16%184.95M
25.55%46.81M
24.34%43.77M
42.67%47.26M
92.36%47.11M
90.75%130.1M
43.74%37.28M
101.18%35.2M
146.78%33.13M
Operating profit
2.43%-56.84M
-34.67%-223.12M
-13.07%-53.95M
-19.32%-52.33M
-38.85%-58.58M
-82.49%-58.26M
-90.30%-165.69M
-46.62%-47.71M
-86.62%-43.86M
-148.71%-42.19M
Net non-operating interest income expense
46.70%8.14M
237.35%23.17M
40.88%6.34M
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
4,735.92%6.87M
6,932.81%4.5M
3,628.30%1.98M
6,060.00%308K
Non-operating interest income
46.70%8.14M
----
----
195.60%5.84M
1,665.58%5.44M
6,663.41%5.55M
----
----
3,628.30%1.98M
6,060.00%308K
Total other finance cost
----
-237.35%-23.17M
----
----
----
----
-4,735.92%-6.87M
----
----
----
Other net income (expense)
-89.43%78K
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
-572.29%-3.31M
102.61%938K
Other non- operating income (expenses)
-89.43%78K
-88.90%165K
-132.75%-713K
124.26%802K
-170.58%-662K
-55.99%738K
104.45%1.49M
91.13%2.18M
-572.29%-3.31M
102.61%938K
Income before tax
6.44%-48.63M
-26.99%-199.79M
-17.76%-48.32M
-1.11%-45.69M
-31.41%-53.81M
-72.30%-51.98M
-30.77%-157.33M
-30.94%-41.03M
-98.65%-45.19M
22.69%-40.95M
Income tax
106K
418.87%275K
-39.62%32K
67K
176K
0
53K
53K
0
0
Net income
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
Net income continuous Operations
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
Minority interest income
Net income attributable to the parent company
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.23%-48.74M
-27.12%-200.07M
-17.69%-48.35M
-1.26%-45.76M
-31.84%-53.98M
-72.30%-51.98M
-30.81%-157.39M
-31.11%-41.09M
-98.65%-45.19M
22.69%-40.95M
Basic earnings per share
29.76%-0.59
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
-68.09%-0.79
23.96%-0.84
Diluted earnings per share
29.76%-0.59
-7.22%-3.12
-2.99%-0.69
8.86%-0.72
-3.57%-0.87
-35.48%-0.84
35.04%-2.91
-3.08%-0.67
-68.09%-0.79
23.96%-0.84
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 305.63%5.7M505.77%11.76M408.30%5.14M235.52%3.12M2.09M1.4M1.94M1.01M929K0
Operating revenue 305.63%5.7M505.77%11.76M408.30%5.14M235.52%3.12M--2.09M--1.4M--1.94M--1.01M--929K--0
Cost of revenue
Gross profit
Operating expense 4.82%62.54M40.12%234.88M21.28%59.09M23.80%55.45M43.81%60.68M86.88%59.66M92.53%167.63M49.73%48.72M90.58%44.79M148.71%42.19M
Selling and administrative expenses 12.83%14.16M33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M59.68%9.59M156.06%9.07M
-General and administrative expense 12.83%14.16M33.05%49.94M7.37%12.28M21.83%11.69M47.97%13.42M68.84%12.55M98.96%37.53M73.28%11.44M59.68%9.59M156.06%9.07M
Research and development costs 2.69%48.38M42.16%184.95M25.55%46.81M24.34%43.77M42.67%47.26M92.36%47.11M90.75%130.1M43.74%37.28M101.18%35.2M146.78%33.13M
Operating profit 2.43%-56.84M-34.67%-223.12M-13.07%-53.95M-19.32%-52.33M-38.85%-58.58M-82.49%-58.26M-90.30%-165.69M-46.62%-47.71M-86.62%-43.86M-148.71%-42.19M
Net non-operating interest income expense 46.70%8.14M237.35%23.17M40.88%6.34M195.60%5.84M1,665.58%5.44M6,663.41%5.55M4,735.92%6.87M6,932.81%4.5M3,628.30%1.98M6,060.00%308K
Non-operating interest income 46.70%8.14M--------195.60%5.84M1,665.58%5.44M6,663.41%5.55M--------3,628.30%1.98M6,060.00%308K
Total other finance cost -----237.35%-23.17M-----------------4,735.92%-6.87M------------
Other net income (expense) -89.43%78K-88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M-572.29%-3.31M102.61%938K
Other non- operating income (expenses) -89.43%78K-88.90%165K-132.75%-713K124.26%802K-170.58%-662K-55.99%738K104.45%1.49M91.13%2.18M-572.29%-3.31M102.61%938K
Income before tax 6.44%-48.63M-26.99%-199.79M-17.76%-48.32M-1.11%-45.69M-31.41%-53.81M-72.30%-51.98M-30.77%-157.33M-30.94%-41.03M-98.65%-45.19M22.69%-40.95M
Income tax 106K418.87%275K-39.62%32K67K176K053K53K00
Net income 6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M
Net income continuous Operations 6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M
Minority interest income
Net income attributable to the parent company 6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.23%-48.74M-27.12%-200.07M-17.69%-48.35M-1.26%-45.76M-31.84%-53.98M-72.30%-51.98M-30.81%-157.39M-31.11%-41.09M-98.65%-45.19M22.69%-40.95M
Basic earnings per share 29.76%-0.59-7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67-68.09%-0.7923.96%-0.84
Diluted earnings per share 29.76%-0.59-7.22%-3.12-2.99%-0.698.86%-0.72-3.57%-0.87-35.48%-0.8435.04%-2.91-3.08%-0.67-68.09%-0.7923.96%-0.84
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg